HB 2385: Prohibits drug manufacturers from interfering directly or indirectly with a pharmacy or drug outlet acquiring 340B drugs, delivering 340B drugs to certain health care providers or dispensing 340B drugs.
Public testimony analysis — 41 testimonies submitted
Testimony Sentiment
78.0%
7
Support
32
Oppose
2
Neutral
Organizational Positions10 organizations
opposeopposeopposeopposeopposeopposeopposesupportsupportsupport
Community Access National Network
1 testimonies · 1 oppose
Community Action for Responsible Hospitals
1 testimonies · 1 oppose
Community Oncology Alliance COA
1 testimonies · 1 oppose
Infusion Access Foundation
1 testimonies · 1 oppose
National Alliance Healthcare Purchaser Coalitions
1 testimonies · 1 oppose
National Taxpayers Union
1 testimonies · 1 oppose
Our Health Equity
1 testimonies · 1 oppose
Salem Health Hospitals and Clinics
1 testimonies · 1 support
Samaritan Health Services
1 testimonies · 1 support
Virginia Garcia Memorial Health Center
1 testimonies · 1 support
Individual Testimony by Location24 locations
| Location | Total | Support | Oppose |
|---|---|---|---|
| Eli Lilly and Company | 3 | 0 | 3 |
| Oregon State Senate | 2 | 0 | 2 |
| Portland | 2 | 0 | 2 |
| Biotechnology Innovation Organization | 2 | 0 | 2 |
| Salem | 2 | 0 | 2 |
| Tigard | 2 | 2 | 0 |
| GSK | 1 | 0 | 1 |
| Kansas City | 1 | 0 | 1 |
| Troutdale | 1 | 0 | 1 |
| AstraZeneca | 1 | 0 | 1 |
| Aumsville | 1 | 1 | 0 |
| Bend | 1 | 0 | 1 |
| Conquest Advisors | 1 | 0 | 0 |
| EUGENE | 1 | 0 | 1 |
| Johnson and Johnson | 1 | 0 | 1 |
| Kaleidoscope Fighting Lupus | 1 | 0 | 1 |
| Lebanon | 1 | 0 | 1 |
| MEDFORD | 1 | 0 | 1 |
| Milwaukee WI | 1 | 0 | 1 |
| PhRMA | 1 | 0 | 1 |
| REDMOND | 1 | 0 | 1 |
| Southern Oregon | 1 | 0 | 1 |
| The Kent Group | 1 | 0 | 0 |
| tigard | 1 | 1 | 0 |